Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ertapenem PK in Urosepsis
NCT03859362Phase 4Unknown
- Sponsor
- Prince of Songkla University
- Start
- Jan 2017
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ertapenem in urosepsis, sponsored by Prince of Songkla University. Primary endpoint: Concentration of ertapenem in plasma at 24 hours. Status: unknown.
02
Drugs
ertapenem
03
Conditions
urosepsis
Beyond the preview
Go deeper on NCT03859362.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03859362.